stella
beta
The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) — Stella
Recruiting
Back to Metastatic Colorectal Cancer (mCRC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(7 sites)
United States
City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California
Pacific Hematology Oncology Associates, San Francisco, California
Georgetown University Medical Center, Washington D.C., District of Columbia
Norton Cancer Institute, Brownsboro Hospital Campus, Louisville, Kentucky
University of Nebraska Medical Center, Omaha, Nebraska
Show all 7 locations
View full record on ClinicalTrials.gov